Log In
Print this Print this

Toctino, alitretinoin (BAL4079)

  Manage Alerts
Collapse Summary General Information
Company Basilea Pharmaceutica AG
DescriptionVitamin A derived 9-cis retinoic acid
Molecular Target Retinoic acid receptor (RAR)
Mechanism of ActionRetinoic acid receptor (RAR) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDermatitis
Indication DetailsTreat chronic hand dermatitis; Treat severe chronic hand eczema
Regulatory Designation
Partner Almirall S.A.; GlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today